Published on Monday June 06, 2022

We are working on the following new projects:

  • Smooth signed a contract for a bioequivalence trial with Rivaroxaban.
  • We signed two contracts for medical writing services and two other contracts for publications preparation with different clients.

We are happy to reach the following milestones in our projects:

  • The enrollment starts in all sites in the trial with Nimesulide 2% gel.
  • The CSR in the Azacitidine trial was finalized.
  • The CTAs were received in the Sildenafil and Rivaroxaban studies.